Position in CELC
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$6,210,014
+$1,972,561 QoQ
Shares Held
54,407
+28.1% QoQ
Ownership
0.112%
of shares outstanding
% of Portfolio
1.77%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in CELC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Harvest Investment Services, LLC holds $26,394,041 across 17 Biotechnology names. CELC ranks #1 (23.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CELC |
Celcuity Inc.
This page
|
54,407 | $6,210,014 | |
| 2 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
48,468 | $4,215,261 | |
| 3 | TERN |
Terns Pharmaceuticals, Inc.
|
51,887 | $2,735,482 | |
| 4 | KOD |
Kodiak Sciences Inc.
|
71,349 | $2,719,823 | |
| 5 | ALMS |
Alumis Inc.
|
99,850 | $2,199,695 | |
| 6 | STOK |
Stoke Therapeutics, Inc.
|
62,838 | $2,046,005 | |
| 7 | COGT |
Cogent Biosciences, Inc.
|
50,889 | $1,958,717 | |
| 8 | ERAS |
Erasca, Inc.
|
73,744 | $1,193,177 |
All Filings in CELC
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $6,210,014 | 54,407 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $4,237,453 | 42,485 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $1,426,573 | 28,878 | Shares | Sole | 2025-11-17 | |
| No filing history on record for this holder in this stock. | ||||||